Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emerging E-health Companies (7/00)

This article was originally published in Start Up

Executive Summary

Showcasing recently founded companies in the e-health arena: GlobeRx.com Inc. will facilitate pharmaceutical procurement for health care institutions and organizations in second and third world countries. MedCompanion Inc. offers wireless, handheld billing-related systems for physicians. MyDoc Online Inc. is an Internet portal to facilitate doctor-patient communication: appointment scheduling, prescription refills, medical test results, insurance eligibility and referrals. TargetRx Inc. is an Internet forum for physicians to provide direct product feedback to pharmaceutical companies through validated surveys and other market research instruments. Yourdoctor Inc.'s proprietary graphical navigation system places health care information in context for user, creates vertical markets for providers, suppliers.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC090270

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel